Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Pharmacy committee asks staff to broaden buprenorphine guidance for pharmacists
Summary
At its June 12, 2025 meeting the California State Board of Pharmacy Communication and Public Education Committee reviewed a draft educational sheet on buprenorphine, asked staff to clarify terms and add clinical resources, and confirmed the board will distribute the sheet via its alert list, newsletter and website.
The California State Board of Pharmacy Communication and Public Education Committee reviewed and requested revisions to a draft informational sheet on buprenorphine at its June 12, 2025 meeting, asking staff to clarify technical terms, add links to clinical guidelines and consider continuing-education resources for pharmacists.
Members said the draft, prepared by staff and outside experts, should more clearly reconcile pharmacists’ “corresponding responsibility” to detect diversion and the clinical role of buprenorphine as treatment for opioid use disorder. Nicole Thiebaud, chairperson of the Communication and Public Education Committee, said the board intends to distribute the informational sheet "through the board's Scribe alert, and it will be included in future newsletters and will be posted on the website."
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
